Duchenne muscular dystrophy gene therapy approval rests on surrogate biomarker data. Read the latest in The Clinical Pipeline, from cyrilpedia
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser . In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Inside the nascent industry of AI-designed drugs - Nature MedicineArtificial intelligence tools are beginning to upend the drug discovery pipeline, with several new compounds entering clinical trials.
Weiterlesen »
Researchers and regulators plan for a future without lab animals - Nature MedicineThe US Food and Drug Administration has reduced requirements for preclinical animal testing, leading to a surge of interest in organoids, tissue chips and in silico testing.
Weiterlesen »
‘It’s a vote for hope’: first gene therapy for muscular dystrophy nears approval, but will it work?The FDA’s decision, expected this month, follows several setbacks and delays and will pose difficult choices for the families of children with Duchenne muscular dystrophy.
Weiterlesen »
‘MacGyver med’ and rock-and-roll: Event medicine is the ticket for someLarge-event medical services started becoming more formalized about 20 years ago. From Coachella to the Preakness to Lollapalooza, these doctors see it all: blue patients, drunken falls and overheated dancers.
Weiterlesen »
Delaware man is first Penn Medicine patient to receive robotic kidney transplantA Delaware musician has a new lease on life after a kidney transplant. It was an operation that involved a robot and social media.
Weiterlesen »
Stanford Medicine Reveals: Tiny DNA Circles Defying Genetic Laws Drive Cancer FormationTiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during the transformation from pre-cancer to cancer, say Stanford Medicine-led team. Tiny circles of DNA that defy the accepted laws of genetics are key drivers of cancer for
Weiterlesen »